Skip to Content

M161 M161 (Didanosine Delayed Release 250 mg)

Pill with imprint M161 M161 is Yellow, Capsule-shape and has been identified as Didanosine Delayed Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M161 M161

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide